Literature DB >> 28210802

Poorly-differentiated colorectal neuroendocrine tumour: CT differentiation from well-differentiated neuroendocrine tumour and poorly-differentiated adenocarcinomas.

Ji Hee Kang1, Se Hyung Kim2,3, Joon Koo Han1,4,5.   

Abstract

OBJECTIVE: The differentiation of poorly-differentiated neuroendocrine tumours (PD-NETs), well-differentiated NETs (WD-NETs), and adenocarcinomas (ADCs) is important due to different management options and prognoses. This study is to find the differential CT features of colorectal PD-NETs from WD-NETs and ADCs.
MATERIALS AND METHODS: CT features of 25 colorectal WD-NETs, 36 PD-NETs, and 36 ADCs were retrospectively reviewed. Significant variables were assessed using univariate and multivariate analyses. Receiver operating characteristics analysis determined the optimal cut-off value of tumour and lymph node (LN) size.
RESULTS: Large size, rectum location, ulceroinfiltrative morphology without intact overlying mucosa, heterogeneous attenuation with necrosis, presence of ≥3 enlarged LNs, and metastasis were significant variables to differentiate PD-NETs from WD-NETs (P < 0.05). High attenuation on arterial phase, persistently high enhancement pattern, presence of ≥6 enlarged LNs, large LN size, and wash-in/wash-out enhancement pattern of liver metastasis were significant variables to differentiate PD-NETs from ADCs (P < 0.05).
CONCLUSIONS: Compared to WD-NETs, colorectal PD-NETs are usually large, heterogeneous, and ulceroinfiltrative mass without intact overlying mucosa involving enlarged LNs and metastasis. High attenuation on arterial phase, presence of enlarged LNs with larger size and greater number, and wash-in/wash-out enhancement pattern of liver metastasis can be useful CT discriminators of PD-NETs from ADCs. KEY POINTS: • Compared to WD-NETs, PD-NETs more frequently accompany enlarged LNs and metastases. • Metastatic LNs from PD-NETs are significantly larger than those from ADCs. • Hepatic metastases from PD-NETs usually show early enhancement and delayed washout.

Entities:  

Keywords:  Adenocarcinoma; CT; Colorectum; Differentiation; Neuroendocrine tumour

Mesh:

Year:  2017        PMID: 28210802     DOI: 10.1007/s00330-017-4764-5

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  17 in total

1.  Survival of patients with neuroendocrine carcinoma of the colon and rectum: a population-based analysis.

Authors:  Hammad Shafqat; Shihab Ali; Mohammed Salhab; Adam J Olszewski
Journal:  Dis Colon Rectum       Date:  2015-03       Impact factor: 4.585

Review 2.  Pathologic research update of colorectal neuroendocrine tumors.

Authors:  Shu-Juan Ni; Wei-Qi Sheng; Xiang Du
Journal:  World J Gastroenterol       Date:  2010-04-14       Impact factor: 5.742

Review 3.  Imaging features of carcinoid tumors of the gastrointestinal tract.

Authors:  Dhakshina Ganeshan; Priya Bhosale; Thomas Yang; Vikas Kundra
Journal:  AJR Am J Roentgenol       Date:  2013-10       Impact factor: 3.959

4.  Tiny carcinoids may be malignant.

Authors:  F Seow-Cheoen; J Ho
Journal:  Dis Colon Rectum       Date:  1993-03       Impact factor: 4.585

5.  The NANETS consensus guidelines for the diagnosis and management of poorly differentiated (high-grade) extrapulmonary neuroendocrine carcinomas.

Authors:  Jonathan R Strosberg; Domenico Coppola; David S Klimstra; Alexandria T Phan; Matthew H Kulke; Gregory A Wiseman; Larry K Kvols
Journal:  Pancreas       Date:  2010-08       Impact factor: 3.327

Review 6.  One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States.

Authors:  James C Yao; Manal Hassan; Alexandria Phan; Cecile Dagohoy; Colleen Leary; Jeannette E Mares; Eddie K Abdalla; Jason B Fleming; Jean-Nicolas Vauthey; Asif Rashid; Douglas B Evans
Journal:  J Clin Oncol       Date:  2008-06-20       Impact factor: 44.544

7.  To be or not to be: significance of lymph nodes on pretreatment CT in predicting survival of rectal cancer patients.

Authors:  Yong-Kun Chi; Xiao-Peng Zhang; Jie Li; Ying-Shi Sun
Journal:  Eur J Radiol       Date:  2009-10-22       Impact factor: 3.528

8.  Gastroenteropancreatic neuroendocrine tumors: role of imaging in diagnosis and management.

Authors:  Dushyant V Sahani; Pietro A Bonaffini; Carlos Fernández-Del Castillo; Michael A Blake
Journal:  Radiology       Date:  2013-01       Impact factor: 11.105

9.  TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system.

Authors:  G Rindi; G Klöppel; H Alhman; M Caplin; A Couvelard; W W de Herder; B Erikssson; A Falchetti; M Falconi; P Komminoth; M Körner; J M Lopes; A-M McNicol; O Nilsson; A Perren; A Scarpa; J-Y Scoazec; B Wiedenmann
Journal:  Virchows Arch       Date:  2006-09-12       Impact factor: 4.064

10.  CT/MRI of neuroendocrine tumours.

Authors:  Rodney H Reznek
Journal:  Cancer Imaging       Date:  2006-10-31       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.